NicholasFontaineEvageliouMD

Pediatric Hematology & Oncology • Philadelphia, PA

Assistant Professor, Pediatrics, Perelman School of Medicine

Join to view full profile

Dr. Evageliou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Evageliou's full profile

Already have an account?

Office
3401 Civic Center Blvd
# Children
Philadelphia, PA 19104
Phone+1 215-590-3535

Fax+1 215-590-3992

Education & Training

Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2005 - 2008
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2002 - 2005
Uconn School Of MedicineClass of 2002

Certifications & Licensure

NJ State Medical License 2009 - 2025
PA State Medical License 2002 - 2024
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

180 citations
ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.
Michael D. Hogarty, Murray D. Norris, Kimberly A. Davis, Xueyuan Liu, Nicholas F. Evageliou
Cancer Research. 2008-12-01
60 citations
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression.
Nicholas F. Evageliou, Michelle Haber, Annette Vu, Theodore W. Laetsch, Jayne Murray
Clinical Cancer Research. 2016-09-01
2 citations
Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Gro...
Nicholas Evageliou, Lindsay A Renfro, James Geller, Elizabeth Perlman, John Kalapurakal
Cancer. 2024-03-01